Suppression of CDK2 expression by siRNA induces cell cycle arrest and cell proliferation inhibition in human cancer cells

BMB Reports

Volumn 43, Issue 4, 2010, Pages 291-296

  Long, Xiang E ^a   Gong, Zhao Hui ^a   Pan, Lin ^a   Zhong, Zhi Wei ^a   Le, Yan Ping ^a   Liu, Qiong ^a   Guo, Jun Ming ^a   Zhong, Jiu Chang ^a  

^a NINGBO UNIVERSITY   (China)

Author keywords

Cell cycle; Cell proliferation; Cyclin dependent kinase 2; RNA interference; Small interference RNA

Indexed keywords

EUKARYOTA;

EID: 77953518537     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2010.43.4.291     Document Type: Article

References (39)

1. Nurse, P. (2002) Cyclin dependent kinases and cell cycle control (nobel lecture). Chembiochem. 3, 596-603.
2. Murray, A. W. (2004) Recycling the Cell Cycle: Cyclins Revisited. Cell 116, 221-334.
3. Gong, L., Jiang, C., Zhang, B., Hu, H., Wang, W. and Liu, X. (2006) Adenovirus-mediated expression of both antisense ornithine decarboxylase and S-adenosylmethionine decarboxylase induces G1 arrest in HT-29 Cells. J. Biochem. Mol. Biol. 39, 730-736.
4. Larochelle, S., Merrick, K. A., Terret, M. E., Wohlbold, L., Barboza, N. M., Zhang, C., Shokat, K. M., Jallepalli, P. V. and Fisher, R. P. (2007) Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of cdk2 revealed by chemical genetics in human cells. Mol. Cell 25, 839-850.
5. Wandl, S. and Wesierska-Gadek, J. (2009) Is olomoucine, a weak cdk2 inhibitor, able to induce apoptosis in cancer cells? Ann. N Y Acad. Sci. 1171, 242-249.
6. Du, J., Widlund, H. R., Horstmann, M. A., Ramaswamy, S., Ross, K., Huber, W. E., Nishimura, E. K., Golub, T. R. and Fisher, D. E. (2004) Critical role of cdk2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer Cell 6, 565-576.
7. Narayanan, R., Adigun, A. A., Edwards, D. P. and Weigel, N. L. (2005) Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/cdk2 as a progesterone receptor coactivator. Mol. Cell Biol. 25, 264-277.
8. Jablonska, B., Aguirre, A., Vandenbosch, R., Belachew, S., Berthet, C., Kaldis, P. and Gallo, V. (2007) cdk2 is critical for proliferation and self-renewal of neural progenitor cells in the adult subventricular zone. J. Cell Biol. 179, 1231-1245.
9. Li, X., Kim, J. W., Grønborg, M., Urlaub, H., Lane, M. D. and Tang, Q. Q. (2007) Role of cdk2 in the sequential phosphorylation/activation of C/EBP during adipocyte differentiation. Proc. Natl. Acad. Sci. U.S.A. 104, 11597-11602.
10. Neganova, I., Zhang, X., Atkinson, S. and Lako, M. (2009) Expression and functional analysis of G1 to S regulatory components reveals an important role for cdk2 in cell cycle regulation in human embryonic stem cells. Oncogene 28, 20-30.
11. Nakano, T., Ohno, T., Ishikawa, H., Suzuki, Y. and Takahashi, T. (2010) Current advancement in radiation therapy for uterine cervical cancer. J. Radiat. Res. (Tokyo) 51, 1-8.
12. Nakano, T., Kato, S., Ohno, T., Tsujii, H., Sato, S., Fukuhisa, K. and Arai, T. (2005) Long-term results of highdose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix. Cancer 103, 92-101.
13. Whelan, J., Patterson, D., Perisoglou, M., Bielack, S., Marina, N., Smeland, S. and Bernstein, M. (2010) The role of interferons in the treatment of osteosarcoma. Pediatr Blood Cancer 54, 350-354.
14. Müller, C. R., Smeland, S., Bauer, H. C., Saeter, G. and Strander, H. (2005) Interferon-alpha as the only adjuvant treatment in high-grade osteosarcoma: long term results of the Karolinska Hospital series. Acta Oncol. 44, 475-480.
15. Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E. and Mello, C. C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811.
16. Tuschl, T., Zamore, P. D., Lehmann, R., Bartel, D. P. and Sharp, P. A. (1999) Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev. 13, 3191-3197.
17. Fjose, A., Ellingsen, S., Wargelius, A. and Seo H. C. (2001) RNA interference: mechanisms and applications. Biotechnol. Annu. Rev. 7, 31-57.
18. Bantounas, I., Phylactou, L. A. and Uney, J. B. (2004) RNA interference and the use of small interfering RNA to study gene function in mammalian systems. J. Mol. Endocrinol. 33, 545-557.
19. Martin, S. E. and Caplen, N. J. (2007) Applications of RNA interference in mammalian systems. Annu. Rev. Genomics Hum. Genet. 8, 81-108.
20. Kim, D. and Rossi, J. (2008) RNAi mechanisms and applications. Biotechniques 44, 613-616.
21. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K. and Tuschl, T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
22. Kim, J., Kim, H., Lee, Y., Yang, K., Byun, S. and Han, K. (2006) A simple and economical short-oligonucleotidebased approach to shRNA generation. J. Biochem. Mol. Biol. 39, 329-334.
23. McIntyre, G. J. and Fanning, G. C. (2006) Design and cloning strategies for constructing shRNA expression vectors. BMC Biotechnol. 6, 1-8.
24. Whitehead, K. A., Langer, R. and Anderson, D. G. (2009) Knocking down barriers:advances in siRNA delivery. Nat. Rev. Drug. Discov. 8, 129-138.
25. Sui, G., Soohoo, C., Affarel, B., Gay, F., Shi, Y., Forrester, W. C. and Shi, Y. (2002) A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 99, 5515-5520.
26. Ammosova, T., Berro, R., Kashanchi, F. and Nekhai, S. (2005) RNA interference directed to cdk2 inhibits HIV-1 transcription. Virology 341, 171-178.
27. Lai, S. R., Andrews, L. G. and Tollefsbol, T. O. (2007) RNA interference using a plasmid construct expressing short-hairpin RNA. Methods Mol. Biol. 405, 31-37.
28. Park, K. J. and Soslow, R. A. (2009) Current concepts in cervical pathology. Arch.Pathol. Lab. Med. 133, 729-738.
29. Schwartz, L. A. (2009) Cervical cancer: disease prevention and informational support. Can. Oncol. Nurs. J. 19, 6-9.
30. Messerschmitt, P. J., Garcia, R. M., Abdul-Karim, F. W., Greenfield, E. M. and Getty, P. J. (2009) Osteosarcoma. J. Am. Acad. Orthop. Surg. 17, 515-527.
31. Li, K., Lin, S. Y., Brunicardi, F. C. and Seu, P. (2003) Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma. Cancer Res. 63, 3593-3597.
32. Wu, H., Hait, W. N. and Yang, J. M. (2003) Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells. Cancer Res. 63, 1515-1519.
33. Xu, X. M., Wang, D., Shen, Q., Chen, Y. Q. and Wang, M. H. (2004) RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectalcarcinoma cells. Oncogene 23, 8464-8474.
34. Lapteva, N., Yang, A. G., Sanders, D. E., Strube, R. W. and Chen, S. Y. (2005) CXCR4 knokdown by small interfering RNA abrogates breast tumor growth in vivo. Cancer Gene Ther. 12, 84-89.
35. Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W. S. and Khvorova, A. (2004) Rational siRNA design for RNA interference. Nat. Biotechnol. 22, 326-330.
36. Elbashir, S. M., Lendeckel, W. and Tuschl, T. (2001) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15, 188-200.
37. Zeng, Y. and Cullen, B. R. (2002) RNA interference in human cells is restricted to the cytoplasm. RNA 8, 855-860.
38. Kawasaki, H. and Taira, K. (2003) Short hairpin type of dsRNAs that are controlled by tRNAVal promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. Nucleic Acids Res. 31, 700-707.
39. Shukla, V., Coumoul, X. and Deng, C. X. (2007) RNAi-based conditional geneknockdown in mice using a U6 promoter driven vector. Int. J. Biol. Sci. 3, 91-99.